SEEBRI Trademark

Trademark Overview


On Monday, August 5, 2013, a trademark application was filed for SEEBRI with the United States Patent and Trademark Office. The USPTO has given the SEEBRI trademark a serial number of 86028642. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2017. This trademark is owned by Novartis AG. The SEEBRI trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations ...
seebri

General Information


Serial Number86028642
Word MarkSEEBRI
Filing DateMonday, August 5, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2013

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 12, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, March 20, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 20, 2017ABANDONMENT - NO USE STATEMENT FILED
Friday, August 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 18, 2016EXTENSION 5 GRANTED
Sunday, August 7, 2016EXTENSION 5 FILED
Sunday, August 7, 2016TEAS EXTENSION RECEIVED
Saturday, February 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 12, 2016EXTENSION 4 GRANTED
Tuesday, February 9, 2016EXTENSION 4 FILED
Tuesday, February 9, 2016TEAS EXTENSION RECEIVED
Wednesday, August 19, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 18, 2015EXTENSION 3 GRANTED
Thursday, June 4, 2015EXTENSION 3 FILED
Tuesday, August 4, 2015TEAS EXTENSION RECEIVED
Tuesday, March 24, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 23, 2015EXTENSION 2 GRANTED
Friday, February 6, 2015EXTENSION 2 FILED
Saturday, March 21, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 6, 2015TEAS EXTENSION RECEIVED
Tuesday, August 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 8, 2014EXTENSION 1 GRANTED
Friday, August 8, 2014EXTENSION 1 FILED
Friday, August 8, 2014TEAS EXTENSION RECEIVED
Tuesday, February 11, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 8, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 7, 2013ASSIGNED TO EXAMINER
Monday, August 12, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 8, 2013NEW APPLICATION ENTERED IN TRAM